Dow Jones

38,686.32

1.51%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BFRIW

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
22/05/2024	15:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BFRIW	Biofrontera Inc
22/05/2024	15:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BFRIW	Biofrontera Inc
09/05/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BFRIW	Biofrontera Inc
16/12/2022	07:30	GlobeNewswire Inc.	Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of Stockholders	NASDAQ:BFRIW	Biofrontera Inc
30/11/2022	13:08	GlobeNewswire Inc.	Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference	NASDAQ:BFRIW	Biofrontera Inc
28/11/2022	10:05	GlobeNewswire Inc.	BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022	NASDAQ:BFRIW	Biofrontera Inc
21/11/2022	07:48	GlobeNewswire Inc.	Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk	NASDAQ:BFRIW	Biofrontera Inc
14/11/2022	07:45	GlobeNewswire Inc.	Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update	NASDAQ:BFRIW	Biofrontera Inc
10/11/2022	10:52	GlobeNewswire Inc.	Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022	NASDAQ:BFRIW	Biofrontera Inc
08/11/2022	15:45	GlobeNewswire Inc.	Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG	NASDAQ:BFRIW	Biofrontera Inc
31/10/2022	07:55	GlobeNewswire Inc.	Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG	NASDAQ:BFRIW	Biofrontera Inc
24/10/2022	06:45	GlobeNewswire Inc.	Biofrontera Inc. Names Fred Leffler as Chief Financial Officer	NASDAQ:BFRIW	Biofrontera Inc
20/10/2022	10:40	GlobeNewswire Inc.	Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference	NASDAQ:BFRIW	Biofrontera Inc
18/10/2022	09:30	GlobeNewswire Inc.	Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference	NASDAQ:BFRIW	Biofrontera Inc
14/10/2022	07:40	GlobeNewswire Inc.	Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan	NASDAQ:BFRIW	Biofrontera Inc
12/10/2022	13:00	GlobeNewswire Inc.	BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022	NASDAQ:BFRIW	Biofrontera Inc
05/10/2022	16:00	GlobeNewswire Inc.	Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022	NASDAQ:BFRIW	Biofrontera Inc
29/09/2022	09:04	GlobeNewswire Inc.	Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference	NASDAQ:BFRIW	Biofrontera Inc
26/09/2022	07:30	GlobeNewswire Inc.	Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer Awards	NASDAQ:BFRIW	Biofrontera Inc
13/09/2022	07:30	GlobeNewswire Inc.	Biofrontera Inc. Names Gerard DiGirolamo as National Sales Director	NASDAQ:BFRIW	Biofrontera Inc
06/09/2022	09:31	GlobeNewswire Inc.	Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. Patent	NASDAQ:BFRIW	Biofrontera Inc
18/08/2022	10:04	GlobeNewswire Inc.	Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for Dermatology	NASDAQ:BFRIW	Biofrontera Inc
12/08/2022	07:33	GlobeNewswire Inc.	Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business Update	NASDAQ:BFRIW	Biofrontera Inc
04/08/2022	07:30	GlobeNewswire Inc.	Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022	NASDAQ:BFRIW	Biofrontera Inc
01/08/2022	10:00	GlobeNewswire Inc.	Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH	NASDAQ:BFRIW	Biofrontera Inc
27/07/2022	07:45	GlobeNewswire Inc.	Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement	NASDAQ:BFRIW	Biofrontera Inc
12/07/2022	07:00	GlobeNewswire Inc.	Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022	NASDAQ:BFRIW	Biofrontera Inc
09/06/2022	08:44	GlobeNewswire Inc.	Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence	NASDAQ:BFRIW	Biofrontera Inc
31/05/2022	09:42	GlobeNewswire Inc.	Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference	NASDAQ:BFRIW	Biofrontera Inc
24/05/2022	10:29	GlobeNewswire Inc.	New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz®	NASDAQ:BFRIW	Biofrontera Inc